Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02105168 | Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment(MSN) | unknown | N/A | 2,200 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 10, 2016 | clinicaltrials |
| NCT02759536 | In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma | unknown | Phase 1 / Phase 2 | 30 | The Third Xiangya Hospital of Central South UniversityOTHER | 1 |
| Jun 7, 2016 |
| clinicaltrials |
| NCT02202200 | Phase I-II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation and Pharmacokinetics of PD-0332991 in Patients Suffering Metastatic Melanoma(OPTIMUM) | unknown | Phase 1 / Phase 2 | 40 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 18, 2016 | clinicaltrials |
| NCT02671513 | A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients | unknown | Phase 1 | 30 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 12, 2016 | clinicaltrials |
| NCT01565837 | Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma(SART) | unknown | Phase 2 | 50 | Wolfram SamlowskiOTHER | 1 | Feb 1, 2016 | clinicaltrials |
| NCT02619058 | A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients | unknown | Phase 1 | 20 | Peking University Cancer Hospital & InstituteOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT00477906 | M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma | unknown | Phase 3 | 387 | AVAX TechnologiesINDUSTRY | 0 | Dec 3, 2015 | clinicaltrials |
| NCT02608437 | A Study Investigating SGI-110 in Combination With Ipilimumab in Unresectable or Metastatic Melanoma Patients(NIBIT-M4) | unknown | Phase 1 | 19 | Italian Network for Tumor Biotherapy FoundationOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01882946 | Safety and Efficacy Study of DCVax-Direct in Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Northwest BiotherapeuticsINDUSTRY | 1 | Oct 7, 2015 | clinicaltrials |
| NCT01729663 | Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients | unknown | Phase 2 / Phase 3 | 108 | Laboratorio Pablo Cassara S.R.L.INDUSTRY | 1 | Sep 2, 2015 | clinicaltrials |
| NCT02511119 | Application of Genomic Techniques and Image Processing Using Artificial Intelligence to Obtain a Predictor Model Risk of Melanoma | unknown | — | 300 | Maimónides Biomedical Research Institute of CórdobaOTHER | 0 | Jul 30, 2015 | clinicaltrials |
| NCT01960829 | Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study | unknown | Phase 2 | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 1, 2015 | clinicaltrials |
| NCT00006249 | Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma | unknown | Phase 3 | 1,258 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 18 | Feb 10, 2015 | clinicaltrials |
| NCT00086866 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery | unknown | Phase 2 | 165 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Feb 10, 2015 | clinicaltrials |
| NCT01588847 | Anesthesia and Cancer Recurrence im Malignant Melanoma | unknown | N/A | 230 | University Hospital MuensterOTHER | 1 | Dec 11, 2014 | clinicaltrials |
| NCT01377025 | A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma(STREAM) | unknown | Phase 2 | 200 | Prof. Dr. med. Max. E. ScheulenOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT02142335 | Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma | unknown | Phase 2 | 17 | California Cancer Assocaties for Research & ExcellenceOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00002817 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | unknown | Phase 1 / Phase 2 | 30 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00489944 | Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma | unknown | Phase 2 | 50 | San Diego Pacific Oncology & Hematology AssociatesOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00492505 | Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma | unknown | Phase 2 | 200 | San Diego Pacific Oncology & Hematology AssociatesOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00538005 | Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma | unknown | Phase 1 / Phase 2 | 54 | San Diego Pacific Oncology & Hematology AssociatesOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00002767 | Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma | unknown | Phase 3 | 300 | GlaxoSmithKlineINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00004025 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 1 / Phase 2 | 36 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00010309 | Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma | unknown | Phase 1 / Phase 2 | — | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00070343 | Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301 | unknown | N/A | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00002845 | Interleukin-2 in Treating Patients With Metastatic Melanoma | unknown | Phase 2 | 20 | Blumenthal Cancer Center at Carolinas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00128583 | Vaccine Therapy in Treating Patients With Malignant Melanoma | unknown | Phase 2 | — | CancerVax CorporationINDUSTRY | 2 | Dec 19, 2013 | clinicaltrials |
| NCT00022568 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | unknown | Phase 1 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00037037 | Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma | unknown | Phase 1 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00039234 | Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver | unknown | Phase 3 | — | Maxim PharmaceuticalsINDUSTRY | 4 | Dec 18, 2013 | clinicaltrials |
| NCT00295906 | Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control | unknown | N/A | 4,550 | Rhode Island HospitalOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00391300 | Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions | unknown | Phase 1 | 100 | Eastern Virginia Medical SchoolOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00003747 | Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma | unknown | Phase 1 | 30 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00016055 | Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma | unknown | Phase 1 | 18 | St. Luke's Medical CenterOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00002781 | Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma | unknown | Phase 1 | 15 | Beth Israel Deaconess Medical CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00006035 | Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00017355 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | unknown | Phase 1 | — | Baylor Health Care SystemOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00126685 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | unknown | Phase 1 / Phase 2 | 30 | Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum ErlangenOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00757614 | Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 14,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01018004 | Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma | unknown | — | 178 | University Medical Center GroningenOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01082198 | Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes | unknown | Phase 1 / Phase 2 | 22 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01217398 | Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye | unknown | Phase 2 | 35 | Institut CurieOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00445783 | Study of Families With Melanoma | unknown | — | 3,700 | Leeds Cancer Centre at St. James's University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00450593 | Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma | unknown | — | 5,000 | Leeds Cancer Centre at St. James's University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00672321 | Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma | unknown | — | 2,774 | Leeds Cancer Centre at St. James's University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00897481 | Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | unknown | — | 1,000 | Leeds Cancer Centre at St. James's University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00002455 | Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma | unknown | Phase 3 | — | Centro Oncologico de ExcelenciaOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01782508 | A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma | unknown | Phase 2 | 40 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT01331915 | Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients(THERAVAC) | unknown | Phase 1 / Phase 2 | 23 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Oct 10, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jun 10, 2016source: clinicaltrials